Developer docs
API playgroundTry for free, no card

Search company profiles

Refeyn

Full company profile

uuid0000o4l

Namestring
Refeyn
Legal namestring
Refeyn Ltd.
Websiteurl
refeyn.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Refeyn is a privately held life sciences instrumentation company, founded in 2018 and spun out of the University of Oxford, that develops and commercializes mass photometry, a label-free optical technology for measuring the mass of individual molecules in solution without the use of labels or denaturation. The platform detects light-scattering interference as molecules bind to a glass surface, enabling single-molecule resolution across proteins, nucleic acids, antibody complexes, mRNA and lipid nanoparticles, and viral vectors including AAV, adenoviral, and lentiviral vectors.

The company's product portfolio comprises four core benchtop mass photometers (TwoMP for general molecular mass, MyMassMP for structural biology sample QC, SamuxMP for AAV characterization, and KaritroMP for large viral vectors), automated walkaway variants (TwoMP Auto and SamuxMP Auto), a microfluidics add-on (MassFluidix HC), a GMP-compliant software suite supporting 21 CFR Part 11 and EU GMP Annex 11, and a recurring consumables line including MassGlass slides, MassFerence and SizeFerence calibrants, and alignment kits.

Refeyn generates revenue through a combination of direct enterprise sales of quote-priced instruments, a global distributor network covering markets including China and Japan, a self-serve US eShop for consumables, and recurring service contracts plus software licensing for regulated environments. Its customer base spans large pharma (AstraZeneca), government research (NIH/NHLBI), CDMOs (ABL Europe), and academic structural biology groups, with primary use cases in cell and gene therapy analytics, biologics and bispecific antibody characterization, mRNA therapeutics, structural biology screening, and contract analytical services.

Short descriptiontext

Refeyn, founded in 2018 from the University of Oxford, commercializes mass photometry, a label-free optical technology that measures the mass of individual molecules and viral vectors in solution, selling instruments, automated systems, consumables, and GMP-compliant software to biopharma, CDMOs, and academic researchers in cell and gene therapy, biologics, and structural biology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersOxford, United Kingdom
HQ citystring
Oxford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mass photometry instruments, single-molecule analysis, analytical laboratory instruments, biologics characterization, viral vector analytics
Industry3 codes
PRIMARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHLAGAIAA
Analytical Instruments & Chromatography Systems
SECONDARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Analytical Laboratory Instruments
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Mass Photometry Instruments
TypeHardware Sales
Description

Sale of benchtop mass photometry instruments (TwoMP, MyMassMP, SamuxMP, KaritroMP) and automated variants. Instruments are quote-priced with installation and support services included.

refeyn.com
2Consumables
TypeHardware Sales
Description

Recurring revenue from consumables including MassGlass sample prep kits (UC, NA, Auto formats), MassFerence calibrants, MassFluidix kits, Alignment kits, and SizeFerence calibrants. Sold via eShop for US customers and quote request for international.

refeyn.com
3Service Contracts and Support
TypeSubscription Recurring
Description

Service contracts for instrument maintenance, technical support, and installation/operational qualifications (IQ/OQ) particularly for GMP environments.

refeyn.com
4Software Licenses
TypeLicensing Royalties
Description

GMP-compliant software packages for regulatory environments including ManageMP, AcquireMP, EvaluateMPS for FDA 21 CFR Part 11 compliance.

refeyn.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Consumables sold via eShop with direct pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Various consumables available: MassGlass UC Sample Prep Kit (60 measurements, 10 slides), MassGlass NA Sample Prep Kit, MassFerence P1/P2 calibrants, MassFluidix HC kits, KaritroMP Alignment Kit, MP Alignment Kits. US customers can purchase with credit card or PO. Limited-time promotional pricing at 50% off for existing 25-slide MassGlass NA kits.

refeyn.com
2Instrument pricing requires quote request
ModelOtherBilling cadenceMulti-year contract
Notes

All mass photometry instruments (TwoMP, MyMassMP, SamuxMP, KaritroMP) and automated variants are sold via quote request. No list pricing publicly available. Demo requests available for interested customers.

refeyn.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 13 records shown
1TwoMP
Description

Flagship mass photometer for high-fidelity measurements of molecular mass for proteins and nucleic acids

refeyn.com
+12 more records
Core offering1 text field

Refeyn manufactures and sells benchtop mass photometry instruments that measure the molecular mass of individual proteins, nucleic acids, AAV capsids, and large viral vectors in solution without labels, returning results in 1–5 minutes from nanogram-scale samples. The portfolio includes the TwoMP (general molecular mass), MyMassMP (structural biology QC), SamuxMP (AAV characterization), and KaritroMP (large viral vectors), supported by a consumables line (MassGlass prep kits, MassFerence/SizeFerence calibrants) and a GMP-compliant software suite for regulated biopharma environments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Results in 1-5 minutes vs hours/days for traditional methods
+5 more records
Product overview1 text field

Refeyn offers a portfolio of mass photometry instruments—a label-free single-molecule analysis technology that measures molecular mass directly in solution. The product line includes the flagship TwoMP mass photometer for general molecular mass measurements (30 kDa to 5 MDa), the compact MyMassMP for rapid sample quality checks in structural biology, the SamuxMP optimized for AAV characterization with automated version available, and the KaritroMP for macro mass photometry of larger viral vectors (AdV, LVV). Supporting the instruments is a comprehensive software suite (AcquireMP, DiscoverMP, EvaluateMPS, ManageMP) including GMP-compliant options, and a range of specialized consumables including MassGlass sample prep kits, MassFerence calibrants for different applications, and alignment kits. The platform is complemented by the MassFluidix HC microfluidics add-on for concentrated sample analysis.

Product and service12 records
1TwoMP Mass Photometer
CategoryMass photometry instrument
2MyMassMP Mass Photometer
CategoryMass photometry instrument
3SamuxMP Mass Photometer
CategoryMass photometry instrument
4KaritroMP Macro Mass Photometer
CategoryMass photometry instrument
5MassFluidix HC System
CategoryMass photometry instrument accessory
6SamuxMP GMP Software Package
CategoryGMP-compliant software
7icIEF–Mass Photometry Integrated Bispecific Antibody Workflow
CategoryIntegrated analytical workflow
8MassFerence P2 Calibrant
CategoryCalibrant consumable
9MassFerence P1 Calibrant
CategoryCalibrant consumable
10SizeFerence Calibrant
CategoryCalibrant consumable
11MassGlass UC Sample Prep Kit
CategorySample prep consumable
12MassGlass NA Sample Prep Kit
CategorySample prep consumable
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-04
Description

First-of-its-kind integrated workflow combining Bio-Techne's MauriceFlex icIEF system with Refeyn's TwoMP mass photometry platform. The four-hour workflow enables single-molecule resolution analysis of bispecific antibodies and biosimilars, correlating charge heterogeneity with molecular weight and aggregation using nanogram-level samples. Demonstrated using Mosunetuzumab-axgb and a biosimilar, with findings to be presented at ASMS conference.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative project developing digital twins and process analytical technologies with automated predictive process control for AAV manufacturing. Part of CGT Catapult initiative to standardize and scale AAV manufacturing for systemic diseases.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

UK-based advanced therapy manufacturing organization leading initiative to optimize AAV manufacturing. Refeyn contributing process analytical technologies for automated predictive process control in two-year collaborative project.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Participating in two-year collaborative project with CGT Catapult and Complement Therapeutics intensifying perfusion processes to standardize and scale AAV manufacturing for systemic diseases.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Participating in two-year collaborative project with CGT Catapult and Pharmaron Biologics intensifying perfusion processes to standardize and scale AAV manufacturing.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Part of Spectris plc, Malvern Panalytical is a leading manufacturer of analytical instruments for particle size, molecular weight, and biomolecular characterization, including Zetasizer (DLS), SEC-MALS (OMNISEC), and microcalorimetry. It is the most directly comparable incumbent to Refeyn's biomolecular mass/particle analysis offering, with deep biopharma penetration and global service.

2Wyatt Technology
TypeDirect peer
Description

Wyatt Technology is the dominant provider of multi-angle light scattering (MALS) instrumentation used alongside SEC for absolute molecular weight determination of proteins, nucleic acids, and AAV/LV capsids. It competes most directly with Refeyn's mass photometry value proposition in protein and AAV characterization workflows.

TypeDirect peer
Description

Unchained Labs provides purpose-built analytical tools for biologics formulation, stability, and biophysical characterization. It overlaps directly with Refeyn's protein, antibody, and gene therapy analytical use cases, particularly for bench-top biophysics labs in pharma and biotech.

TypeBroad incumbent
Description

Thermo Fisher is the largest analytical instrument manufacturer globally, with mass spectrometry, chromatography, and biopharma QC product lines that intersect Refeyn's value proposition across protein characterization, AAV analytics, and GMP-compliant software.

TypeBroad incumbent
Description

Agilent offers a broad analytical instrument portfolio covering chromatography, mass spectrometry, and cell analysis. It serves biopharma QC and biophysical characterization use cases that overlap with Refeyn's instrument-and-consumables model.

TypeBroad incumbent
Description

Waters is a leading provider of liquid chromatography, mass spectrometry, and informatics for biopharmaceutical characterization, directly overlapping with Refeyn's protein, antibody, and AAV analytical workflows.

TypeBroad incumbent
Description

Sartorius offers bioprocess and analytics solutions for cell and gene therapy, including AAV/LV production and analytical tools. Its CellGenie and PAT portfolio targets many of the same CGT manufacturing customers as Refeyn's SamuxMP and KaritroMP.

TypeBroad incumbent
Description

Bruker provides high-resolution mass spectrometry and biophysical characterization tools used in structural biology, proteomics, and biopharma QC — directly comparable to Refeyn's TwoMP and MyMassMP value proposition in academic and industrial biophysics labs.

TypeBroad incumbent
Description

Cytiva provides bioprocess and analytical solutions for the cell and gene therapy industry, including AAV manufacturing platforms and analytical technologies. It overlaps with Refeyn's CGT customer base and process analytics positioning, including the CGT Catapult partnership ecosystem.

TypeBroad incumbent
Description

Shimadzu manufactures a broad range of analytical and measurement instruments including mass spectrometry, chromatography, and spectroscopy systems serving biopharmaceutical and life science markets comparable to Refeyn's installed base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Refeyn

Analytical Laboratory Instrumentsrefeyn.com

Refeyn, founded in 2018 from the University of Oxford, commercializes mass photometry, a label-free optical technology that measures the mass of individual molecules and viral vectors in solution, selling instruments, automated systems, consumables, and GMP-compliant software to biopharma, CDMOs, and academic researchers in cell and gene therapy, biologics, and structural biology.

What Refeyn does

Refeyn is a privately held life sciences instrumentation company, founded in 2018 and spun out of the University of Oxford, that develops and commercializes mass photometry, a label-free optical technology for measuring the mass of individual molecules in solution without the use of labels or denaturation. The platform detects light-scattering interference as molecules bind to a glass surface, enabling single-molecule resolution across proteins, nucleic acids, antibody complexes, mRNA and lipid nanoparticles, and viral vectors including AAV, adenoviral, and lentiviral vectors.

The company's product portfolio comprises four core benchtop mass photometers (TwoMP for general molecular mass, MyMassMP for structural biology sample QC, SamuxMP for AAV characterization, and KaritroMP for large viral vectors), automated walkaway variants (TwoMP Auto and SamuxMP Auto), a microfluidics add-on (MassFluidix HC), a GMP-compliant software suite supporting 21 CFR Part 11 and EU GMP Annex 11, and a recurring consumables line including MassGlass slides, MassFerence and SizeFerence calibrants, and alignment kits.

Refeyn generates revenue through a combination of direct enterprise sales of quote-priced instruments, a global distributor network covering markets including China and Japan, a self-serve US eShop for consumables, and recurring service contracts plus software licensing for regulated environments. Its customer base spans large pharma (AstraZeneca), government research (NIH/NHLBI), CDMOs (ABL Europe), and academic structural biology groups, with primary use cases in cell and gene therapy analytics, biologics and bispecific antibody characterization, mRNA therapeutics, structural biology screening, and contract analytical services.

Refeyn firmographics

Firmographics
Name
Refeyn
Legal name
Refeyn Ltd.
Website
https://refeyn.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
101–250 employees
Short description
Refeyn, founded in 2018 from the University of Oxford, commercializes mass photometry, a label-free optical technology that measures the mass of individual molecules and viral vectors in solution, selling instruments, automated systems, consumables, and GMP-compliant software to biopharma, CDMOs, and academic researchers in cell and gene therapy, biologics, and structural biology.
Ownership category
akta.pro rank

Refeyn industry classification

Industry
Product category
Analytical Laboratory Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHLAGAIAA
Analytical Instruments & Chromatography Systems
SECONDARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments

Keywords

  • Mass photometry instruments
  • Single-molecule analysis
  • Analytical laboratory instruments
  • Biologics characterization
  • Viral vector analytics

Where Refeyn is headquartered

Location

Headquarters

HQ city
Oxford
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Refeyn business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Mass Photometry Instruments: Sale of benchtop mass photometry instruments (TwoMP, MyMassMP, SamuxMP, KaritroMP) and automated variants. Instruments are quote-priced with installation and support services included.
  2. Consumables: Recurring revenue from consumables including MassGlass sample prep kits (UC, NA, Auto formats), MassFerence calibrants, MassFluidix kits, Alignment kits, and SizeFerence calibrants. Sold via eShop for US customers and quote request for international.
  3. Service Contracts and Support: Service contracts for instrument maintenance, technical support, and installation/operational qualifications (IQ/OQ) particularly for GMP environments.
  4. Software Licenses: GMP-compliant software packages for regulatory environments including ManageMP, AcquireMP, EvaluateMPS for FDA 21 CFR Part 11 compliance.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goConsumables sold via eShop with direct pricing
OtherMulti-year contractInstrument pricing requires quote request

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Refeyn product offering

Product offering

Core offering

Refeyn manufactures and sells benchtop mass photometry instruments that measure the molecular mass of individual proteins, nucleic acids, AAV capsids, and large viral vectors in solution without labels, returning results in 1–5 minutes from nanogram-scale samples. The portfolio includes the TwoMP (general molecular mass), MyMassMP (structural biology QC), SamuxMP (AAV characterization), and KaritroMP (large viral vectors), supported by a consumables line (MassGlass prep kits, MassFerence/SizeFerence calibrants) and a GMP-compliant software suite for regulated biopharma environments.

Product overview

Refeyn offers a portfolio of mass photometry instruments—a label-free single-molecule analysis technology that measures molecular mass directly in solution. The product line includes the flagship TwoMP mass photometer for general molecular mass measurements (30 kDa to 5 MDa), the compact MyMassMP for rapid sample quality checks in structural biology, the SamuxMP optimized for AAV characterization with automated version available, and the KaritroMP for macro mass photometry of larger viral vectors (AdV, LVV). Supporting the instruments is a comprehensive software suite (AcquireMP, DiscoverMP, EvaluateMPS, ManageMP) including GMP-compliant options, and a range of specialized consumables including MassGlass sample prep kits, MassFerence calibrants for different applications, and alignment kits. The platform is complemented by the MassFluidix HC microfluidics add-on for concentrated sample analysis.

Differentiator

Problem solved

Functional benefit

Brands

  • TwoMP: Flagship mass photometer for high-fidelity measurements of molecular mass for proteins and nucleic acids
  • MyMassMP
  • SamuxMP
  • KaritroMP
  • MassFluidix HC
  • Refeynery
  • MassGlass
  • MassFerence
  • SizeFerence
  • AcquireMP
  • DiscoverMP
  • ManageMP
  • EvaluateMPS

Products and services

  • TwoMP Mass Photometer
  • MyMassMP Mass Photometer
  • SamuxMP Mass Photometer
  • KaritroMP Macro Mass Photometer
  • MassFluidix HC System
  • SamuxMP GMP Software Package
  • icIEF–Mass Photometry Integrated Bispecific Antibody Workflow
  • MassFerence P2 Calibrant
  • MassFerence P1 Calibrant
  • SizeFerence Calibrant
  • MassGlass UC Sample Prep Kit
  • MassGlass NA Sample Prep Kit

Quantifiable outcome

  • Results in 1-5 minutes vs hours/days for traditional methods
  • +5 more outcomes

Companies that use Refeyn

Customer profile

Named customers4 records

Segments6 records

Ideal customer profiles5 records

Refeyn technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Refeyn partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • Bio-Techne CorporationcoreStrategic or Co-development Partner · 4 June 2026First-of-its-kind integrated workflow combining Bio-Techne's MauriceFlex icIEF system with Refeyn's TwoMP mass photometry platform. The four-hour workflow enables single-molecule resolution analysis of bispecific antibodies and biosimilars, correlating charge heterogeneity with molecular weight and aggregation using nanogram-level samples. Demonstrated using Mosunetuzumab-axgb and a biosimilar, with findings to be presented at ASMS conference.
  • Rentschler BiopharmacoreStrategic or Co-development PartnerCollaborative project developing digital twins and process analytical technologies with automated predictive process control for AAV manufacturing. Part of CGT Catapult initiative to standardize and scale AAV manufacturing for systemic diseases.
  • CGT CatapultcoreStrategic or Co-development PartnerUK-based advanced therapy manufacturing organization leading initiative to optimize AAV manufacturing. Refeyn contributing process analytical technologies for automated predictive process control in two-year collaborative project.
  • Pharmaron BiologicscoreStrategic or Co-development PartnerParticipating in two-year collaborative project with CGT Catapult and Complement Therapeutics intensifying perfusion processes to standardize and scale AAV manufacturing for systemic diseases.
  • Complement TherapeuticscoreStrategic or Co-development PartnerParticipating in two-year collaborative project with CGT Catapult and Pharmaron Biologics intensifying perfusion processes to standardize and scale AAV manufacturing.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Refeyn competitors and assessment

Company assessment

Broad incumbents

  • Malvern Panalytical: Part of Spectris plc, Malvern Panalytical is a leading manufacturer of analytical instruments for particle size, molecular weight, and biomolecular characterization, including Zetasizer (DLS), SEC-MALS (OMNISEC), and microcalorimetry. It is the most directly comparable incumbent to Refeyn's biomolecular mass/particle analysis offering, with deep biopharma penetration and global service.
  • Thermo Fisher Scientific: Thermo Fisher is the largest analytical instrument manufacturer globally, with mass spectrometry, chromatography, and biopharma QC product lines that intersect Refeyn's value proposition across protein characterization, AAV analytics, and GMP-compliant software.
  • Agilent Technologies: Agilent offers a broad analytical instrument portfolio covering chromatography, mass spectrometry, and cell analysis. It serves biopharma QC and biophysical characterization use cases that overlap with Refeyn's instrument-and-consumables model.
  • Waters Corporation: Waters is a leading provider of liquid chromatography, mass spectrometry, and informatics for biopharmaceutical characterization, directly overlapping with Refeyn's protein, antibody, and AAV analytical workflows.
  • Sartorius AG: Sartorius offers bioprocess and analytics solutions for cell and gene therapy, including AAV/LV production and analytical tools. Its CellGenie and PAT portfolio targets many of the same CGT manufacturing customers as Refeyn's SamuxMP and KaritroMP.
  • Bruker Corporation: Bruker provides high-resolution mass spectrometry and biophysical characterization tools used in structural biology, proteomics, and biopharma QC — directly comparable to Refeyn's TwoMP and MyMassMP value proposition in academic and industrial biophysics labs.
  • Cytiva (Danaher): Cytiva provides bioprocess and analytical solutions for the cell and gene therapy industry, including AAV manufacturing platforms and analytical technologies. It overlaps with Refeyn's CGT customer base and process analytics positioning, including the CGT Catapult partnership ecosystem.
  • Shimadzu Scientific Instruments: Shimadzu manufactures a broad range of analytical and measurement instruments including mass spectrometry, chromatography, and spectroscopy systems serving biopharmaceutical and life science markets comparable to Refeyn's installed base.

Direct peers

  • Wyatt Technology: Wyatt Technology is the dominant provider of multi-angle light scattering (MALS) instrumentation used alongside SEC for absolute molecular weight determination of proteins, nucleic acids, and AAV/LV capsids. It competes most directly with Refeyn's mass photometry value proposition in protein and AAV characterization workflows.
  • Unchained Labs: Unchained Labs provides purpose-built analytical tools for biologics formulation, stability, and biophysical characterization. It overlaps directly with Refeyn's protein, antibody, and gene therapy analytical use cases, particularly for bench-top biophysics labs in pharma and biotech.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Refeyn social profiles

Digital presence

Refeyn compliance and trust

Trust signal

Compliance2 records

Refeyn financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Refeyn leadership team

Management profile

Number of profiles

Profiles6 records

Refeyn funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Refeyn M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Refeyn

What does Refeyn do?

Refeyn manufactures and sells benchtop mass photometry instruments that measure the molecular mass of individual proteins, nucleic acids, AAV capsids, and large viral vectors in solution without labels, returning results in 1–5 minutes from nanogram-scale samples. The portfolio includes the TwoMP (general molecular mass), MyMassMP (structural biology QC), SamuxMP (AAV characterization), and KaritroMP (large viral vectors), supported by a consumables line (MassGlass prep kits, MassFerence/SizeFerence calibrants) and a GMP-compliant software suite for regulated biopharma environments.

Is Refeyn a public or private company?

Refeyn is a private company. It is classified as venture growth investor backed and is currently operating.

When was Refeyn founded?

Refeyn was founded in 2018. It employs 101 to 250 people.

Where is Refeyn based?

Refeyn is headquartered in Oxford, United Kingdom, in the Europe region.

How does Refeyn make money?

Four revenue lines are on record. Mass Photometry Instruments are the primary driver. The others are consumables, service Contracts and Support and software Licenses.

Who are Refeyn's main competitors?

Broad incumbents on record are Malvern Panalytical, Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Sartorius AG, Bruker Corporation, Cytiva (Danaher) and Shimadzu Scientific Instruments. Direct peers are Wyatt Technology and Unchained Labs.

Does Refeyn have an API?

No public API is recorded for Refeyn.

What industry is Refeyn in?

Refeyn's product category is Analytical Laboratory Instruments. Its primary akta.pro industry code is HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments, with a secondary code of HLAGAIAA, Analytical Instruments & Chromatography Systems. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall StBio-Techne (TECH) Stock Could Be 10.4% Undervalued After Refeyn CollaborationBio-Techne has partnered with Refeyn on a four-hour workflow for analyzing bispecific antibodies and biosimilars at single molecule resolution, combining charge heterogeneity, molecular weight, and aggregation analysis. The company's stock trading at $55.00 appears approximately 10.4% undervalued according to a fair value estimate of $61.42, supported by a shift in portfolio focus including the divestiture of Exosome Diagnostics toward higher-margin core business segments. The analysis notes potential pressure points including weaker biotech funding and tariff or pricing changes, while also highlighting accelerated innovation in automated proteomic instrumentation and digital platforms driving adoption in regulated pharma manufacturing workflows.Labroots Trending Science NewsAccelerating Cryo-EM Structure Determination of Membrane Transport Proteins with Mass PhotometryDr. Howard Young from the University of Alberta presented a webinar demonstrating how Refeyn's TwoMP mass photometer accelerates Cryo-EM structure determination for membrane transport proteins like MgtA and SERCA. The study utilized this tool to optimize sample preparation, resulting in high-resolution structures that reveal ion-binding sites and activation mechanisms for these P-type ATPases.GenengnewsBio-Techne, Refeyn Partner on Workflow for Bispecific Antibody, Biosimilar CharacterizationBio-Techne and Refeyn launched an integrated workflow combining MauriceFlex icIEF fractionation with TwoMP mass photometry to characterize charge and size variants in bispecific antibodies and biosimilars. The workflow correlates charge heterogeneity with molecular weight and aggregation at single-molecule resolution in four hours, reducing reliance on multiple tests.AijournBio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar CharacterizationBio-Techne Corporation and Refeyn announced a first-of-its-kind integrated workflow combining icIEF fractionation with mass photometry for characterizing charge and size variants in bispecific antibodies and biosimilars. The four-hour workflow uses nanogram-level samples to enable single-molecule resolution analysis, directly addressing a historical challenge where size analysis of charge fractions required large sample amounts. The companies demonstrated the workflow using Mosunetuzumab-axgb and a biosimilar, with full findings to be presented at the ASMS conference in San Diego.PR NewswireBio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar CharacterizationBio-Techne Corporation and Refeyn announced a first-of-its-kind integrated workflow combining icIEF fractionation with mass photometry for characterizing bispecific antibodies and biosimilars. The four-hour workflow pairs Bio-Techne's MauriceFlex icIEF system with Refeyn's TwoMP mass photometry platform, enabling researchers to directly correlate charge heterogeneity with molecular weight and aggregation at single-molecule resolution using nanogram-level samples. The companies stated the workflow reduces reliance on multiple tests, lowers development risk, and enables faster, more efficient process development for complex biologics manufacturers.Stock TitanBio-Techne, Refeyn launch 4-hour bispecific assayBio-Techne Corporation and Refeyn announced a first-of-its-kind integrated workflow combining icIEF fractionation with mass photometry for characterizing bispecific antibodies and biosimilars, enabling direct correlation of charge heterogeneity with molecular weight and aggregation at single-molecule resolution. The four-hour workflow addresses a critical characterization challenge in complex biologics development by requiring only nanogram-level samples, reducing development risk and manufacturing costs. The technology was demonstrated using Mosunetuzumab-axgb and will be presented at the ASMS conference in San Diego.News-MedicalBio‑Techne and Refeyn close critical gap in bispecific antibody and biosimilar characterizationBio‑Techne and Refeyn announced an integrated workflow combining MauriceFlex icIEF fractionation with Refeyn's TwoMP mass photometry to characterize charge and size variants in bispecific antibodies and biosimilars. The four-hour workflow requires only nanogram-level samples and enables single-molecule resolution analysis. The approach will be presented at the ASMS conference in June 2026.Financial PostRefeyn launches MyMass instrument to simplify sample quality assessment for structural biologyRefeyn, a developer of mass photometry technology based in Oxford, United Kingdom, announced the launch of MyMassMP, a compact benchtop mass photometer designed to help researchers verify sample quality before committing to costly structural biology experiments such as cryo-EM, native MS, BLI, and SPR. The instrument is built on the same proven technology as Refeyn's existing TwoMP mass photometer and features an integrated display, onboard computer, and dedicated consumables for an streamlined workflow. The product is now available directly from Refeyn, with the company positioning it as making mass photometry accessible to a broader range of researchers in structural biology and biotherapeutics labs.GlobeNewswireRefeyn launches MyMass instrument to simplify sample quality assessment for structural biologyRefeyn launched MyMassMP, a compact mass photometer for assessing sample purity, homogeneity, and oligomerization before structural biology experiments. Built on the same technology as its TwoMP, it offers an integrated display and consumables for an intuitive workflow. The instrument is available now.GlobeNewswireRefeyn launches MyMass instrument to simplify sample quality assessment for structural biologyRefeyn, an Oxford-based developer of mass photometry technology, has launched MyMassMP, a compact benchtop mass photometer designed to help structural biology researchers quickly assess sample quality before committing to resource-intensive experiments. The instrument uses the same proven technology as Refeyn's existing TwoMP system but in a simpler, self-contained format with integrated data analysis capabilities. MyMassMP is now available and is aimed at making mass photometry accessible to a broader range of researchers in structural biology and AI-driven drug discovery workflows.